Home News Breaking News Briefs

Breaking News Briefs

Summaries of current approvals by global regulatory agencies of drugs and other treatment-related therapeutic agents used to treat lung cancer and other thoracic neoplasms.

Breaking News Briefs

Expanded Indication for Pembrolizumab April 11, 2019—The U.S. Food and Drug Administration (FDA) expanded the approval of pembrolizumab in the first-line setting to patients with...

Meeting News